IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX) have received an average recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $60.3333.

Several brokerages have recently issued reports on IPX. Roth Mkm reaffirmed a “buy” rating on shares of IperionX in a report on Monday. BTIG Research lifted their target price on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a report on Friday. B. Riley Financial reduced their target price on IperionX from $58.00 to $52.00 and set a “buy” rating on the stock in a report on Friday, March 13th. Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a report on Tuesday, April 28th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a report on Tuesday, April 21st.

IperionX Trading Down 0.8%

IPX stock opened at $36.04 on Wednesday. The company’s fifty day moving average price is $34.57 and its 200-day moving average price is $38.08. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.03 and a quick ratio of 4.00. IperionX has a one year low of $21.66 and a one year high of $61.45.

IperionX (NASDAQ:IPX) last issued its earnings results on Saturday, January 31st. The company reported ($0.50) earnings per share (EPS) for the quarter. Research analysts forecast that IperionX will post -0.12 EPS for the current year.

Insider Activity

In other news, CEO Anastasios Arima bought 110,000 shares of IperionX stock in a transaction dated Tuesday, April 28th. The shares were purchased at an average cost of $4.49 per share, with a total value of $493,900.00. Following the completion of the acquisition, the chief executive officer owned 12,316,782 shares of the company’s stock, valued at $55,302,351.18. This trade represents a 0.90% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Todd Hannigan purchased 260,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 29th. The stock was bought at an average price of $4.20 per share, with a total value of $1,092,000.00. Following the transaction, the chairman owned 26,108,334 shares of the company’s stock, valued at $109,655,002.80. This represents a 1.01% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought 590,000 shares of company stock worth $2,571,500 over the last ninety days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp purchased a new position in IperionX in the third quarter worth about $36,000. JPMorgan Chase & Co. purchased a new position in IperionX in the second quarter worth about $66,000. State of Tennessee Department of Treasury purchased a new position in IperionX in the fourth quarter worth about $119,000. DV Equities LLC purchased a new position in IperionX in the fourth quarter worth about $178,000. Finally, Man Group plc purchased a new position in IperionX in the fourth quarter worth about $257,000. Hedge funds and other institutional investors own 2.76% of the company’s stock.

IperionX Company Profile

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.